Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Sung-Yeon Park, Kylie Hill, Gi Woong Yun, Sarah Friedman & Max J. Coppes. (2023) Analysis of Direct-To-Consumer Healthcare Service Advertisements on Television: An Application of the Patient Expectation Framework. Health Communication 38:10, pages 2067-2079.
Read now
Read now
Haeran Jae & Devon S. DelVecchio. (2022) Aliterate Consumers’ Processing of Drug Risk Information inDirect-to-Consumer Pharmaceutical Advertising. Journal of Global Marketing 35:2, pages 115-132.
Read now
Read now
Jiawei Liu, Rosemary J. Avery, Jungyon Janice Kim & Jeff Niederdeppe. (2022) Maintaining a Fair Balance? Narrative and Non-Narrative Strategies in Televised Direct-to-Consumer Advertisements for Prescription Drugs Aired in the United States, 2003–2016. Journal of Health Communication 27:3, pages 183-191.
Read now
Read now
Ilwoo Ju, Jennifer E. Ohs & Jin Seong Park. (2020) Consumer’s Regulatory Knowledge of Prescription Drug Advertising and Health Risk Awareness: The Moderating Role of Risk Information Prominence. Health Communication 35:6, pages 696-706.
Read now
Read now
Crystal Adams & Brittany M. Harder. (2019) Lifestyles are risky, too: the social construction of risk and empowerment in prescription drug direct-to-consumer advertisements. Health, Risk & Society 21:1-2, pages 17-34.
Read now
Read now
Helen W. Sullivan, Kathryn J. Aikin & Jon Poehlman. (2019) Communicating Risk Information in Direct-to-Consumer Prescription Drug Television Ads: A Content Analysis. Health Communication 34:2, pages 212-219.
Read now
Read now
Ilwoo Ju & Jin Seong Park. (2018) Effects of risk disclosure prominence in direct-to-consumer advertising (DTCA) of prescription drugs: An integrative cognitive process model. Health Marketing Quarterly 35:1, pages 32-46.
Read now
Read now
Susan Mello. (2012) Selling a super cosmeceutical: Contextualising risk in direct-to-consumer advertising of BOTOX® Cosmetic. Health, Risk & Society 14:4, pages 385-398.
Read now
Read now
Articles from other publishers (19)
Kristen Giombi, Jessica Thompson, Candi Wines, Ryan Haughney, Helen W. Sullivan & Kevin R. Betts. (2023) A scoping review of empirical research on prescription drug promotion. Research in Social and Administrative Pharmacy 19:6, pages 859-872.
Crossref
Crossref
Caroline von Samson-Himmelstjerna. 2023. Standardisierte Inhaltsanalyse in der Kommunikationswissenschaft – Standardized Content Analysis in Communication Research. Standardisierte Inhaltsanalyse in der Kommunikationswissenschaft – Standardized Content Analysis in Communication Research
399
410
.
Jesse King, Christopher Yencha, Leslie Koppenhafer & Robert Madrigal. (2022) A “Clear and Conspicuous” Distraction: Coping with Incongruent Audiovisual Content in Direct-to-Consumer Advertisements. Journal of Public Policy & Marketing 41:4, pages 353-367.
Crossref
Crossref
Keith J. Zullig & Amanda L. Divin. (2021) Quantifying Healthy Days Lost to the Non-Medical Use of Prescription Drugs (NMUPD) among a Sample of College Students. Applied Research in Quality of Life 17:2, pages 655-669.
Crossref
Crossref
Mara Schein, Rosemary J. Avery & Matthew D. Eisenberg. (2021) Missing the Mark: The Long-Term Impacts of the Federal Trade Commission’s Red Flag Initiative to Reduce Deceptive Weight Loss Product Advertising. Journal of Public Policy & Marketing 41:1, pages 89-105.
Crossref
Crossref
Jesse King, Leslie Koppenhafer & Robert Madrigal. (2020) Look, Puppies! A Visual Content Analysis of Required Risk Statements Embedded in Direct-to-Consumer Pharmaceutical Advertising. Journal of Public Policy & Marketing 40:1, pages 45-61.
Crossref
Crossref
Bradley E. Karlin & Lisa A. Brenner. (2020) Improving engagement in evidence‐based psychological treatments among Veterans: Direct‐to‐consumer outreach and pretreatment shared decision‐making.. Clinical Psychology: Science and Practice 27:4.
Crossref
Crossref
Aline Bütikofer, Christopher J. Cronin & Meghan M. Skira. (2020) Employment effects of healthcare policy: Evidence from the 2007 FDA black box warning on antidepressants. Journal of Health Economics 73, pages 102348.
Crossref
Crossref
Nicolette Rainone, Reshma Oodal & Jeff Niederdeppe. (2017) The (Surprising) Impact of Televised Antidepressant Direct-to-Consumer Advertising on the Stigmatization of Mental Illness. Community Mental Health Journal 54:3, pages 267-275.
Crossref
Crossref
Helen W. Sullivan, Vanessa Boudewyns, Amie O'Donoghue, Sandra Marshall & Pamela A. Williams. (2017) Attention to and Distraction from Risk Information in Prescription Drug Advertising: An Eye-Tracking Study. Journal of Public Policy & Marketing 36:2, pages 236-245.
Crossref
Crossref
Matthew D. Eisenberg, Rosemary J. Avery & Jonathan H. Cantor. (2017) Vitamin panacea: Is advertising fueling demand for products with uncertain scientific benefit?. Journal of Health Economics 55, pages 30-44.
Crossref
Crossref
Kathryn J Aikin, Helen W Sullivan, Suzanne Dolina, Molly Lynch & Linda B Squiers. (2017) Direct-to-Consumer Promotion of Prescription Drugs on Mobile Devices: Content Analysis. Journal of Medical Internet Research 19:7, pages e225.
Crossref
Crossref
Cornelia Pechmann & Jesse R Catlin. (2016) The effects of advertising and other marketing communications on health-related consumer behaviors. Current Opinion in Psychology 10, pages 44-49.
Crossref
Crossref
Crystal Adams. (2016) Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis. Journal of Medical Internet Research 18:2, pages e33.
Crossref
Crossref
Joel J Davis & Sandra M Isaacson. (2014) Responses to alternative forms of efficacy descriptions in direct-to-consumer pharmaceutical communications. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing 14:1, pages 57-67.
Crossref
Crossref
Adrienne E. Faerber & David H. Kreling. (2013) Content Analysis of False and Misleading Claims in Television Advertising for Prescription and Nonprescription Drugs. Journal of General Internal Medicine 29:1, pages 110-118.
Crossref
Crossref
Jennifer Ball & Michael Mackert. (2013) Pharmaceutical advertising practitioners' approach to trust and emotion. International Journal of Pharmaceutical and Healthcare Marketing 7:3, pages 244-264.
Crossref
Crossref
Jonathan Gooblar & Brian D. Carpenter. (2013) Print Advertisements for Alzheimer’s Disease Drugs. American Journal of Alzheimer's Disease & Other Dementiasr 28:4, pages 355-362.
Crossref
Crossref
Rosemary J. Avery, Matthew D. Eisenberg & Kosali I. Simon. (2012) The impact of direct-to-consumer television and magazine advertising on antidepressant use. Journal of Health Economics 31:5, pages 705-718.
Crossref
Crossref